prikaz prve stranice dokumenta Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.
Rad nije dostupan
Znanstveni rad - Izvorni znanstveni rad
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.
Atherosclerosis (Amsterdam), 285 (2019); 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014
(ESC- EORP EUROASPIRE V survey) De Backer, Guy; Jankowski, Piotr; Kotseva, Kornelia; Mirrakhimov, Erkin; Reiner, Željko; Ryden, Lars; Tokgözoğlu, Lale; Wood, David; De Bacquer, Dirk

Citirajte ovaj rad

De Backer, G., Jankowski, P., Kotseva, K., Mirrakhimov, E., Reiner, Ž., Ryden, L. ... De Bacquer, D. (2019). Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.. Atherosclerosis (Amsterdam), 285., 135-146. doi: 10.1016/j.atherosclerosis.2019.03.014

De Backer, Guy, et al. "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.." Atherosclerosis (Amsterdam), vol. 285, 2019, str. 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014

De Backer, Guy, Piotr Jankowski, Kornelia Kotseva, Erkin Mirrakhimov, Željko Reiner, Lars Ryden, Lale Tokgözoğlu, David Wood i Dirk De Bacquer. "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.." Atherosclerosis (Amsterdam) 285 (2019): 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014

De Backer, G., et al. (2019) 'Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.', Atherosclerosis (Amsterdam), 285, str. 135-146. doi: 10.1016/j.atherosclerosis.2019.03.014

De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Ryden L, i sur.. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.. Atherosclerosis (Amsterdam) [Internet]. 2019. [pristupljeno 27.12.2024.];285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014

G. De Backer, et al., "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.", Atherosclerosis (Amsterdam), vol. 285, str. 135-146, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:023900. [Citirano: 27.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:023900
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.
AutorGuy De Backer
AutorPiotr Jankowski
AutorKornelia Kotseva
AutorErkin Mirrakhimov
AutorŽeljko Reiner
AutorLars Ryden
AutorLale Tokgözoğlu
AutorDavid Wood
AutorDirk De Bacquer
KolaboracijaESC- EORP EUROASPIRE V survey
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
BACKGROUND AND AIMS: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. METHODS: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C- lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. RESULTS: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self- reported diabetes. CONCLUSIONS: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaAtherosclerosis (Amsterdam)
Brojčani podacivol. 285, str. 135-146
p-ISSN0021-9150
DOIhttps://doi.org/10.1016/j.atherosclerosis.2019.03.014
URN:NBNurn:nbn:hr:184:023900
Datum objave publikacije2019
URL dokumentahttp://bib.irb.hr/999699
Vrsta resursaTekst
Prava pristupaZatvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-02-18 12:47:23